Search research articles
Contact Us
Filters
Showing results (721-730 of 736) with videos related to
Page
of 74
Sort By:
BMC Medical Education
|
July 2, 2025
Achievement emotions in healthcare education: understanding the application of achievement emotions questionnaire
Fraide A Ganotice, Xiaoai Shen, John Ian Wilzon Tolentino Dizon, et al.
Nature Biotechnology
|
April 28, 2022
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Jason Z Zhang, Hsien-Wei Yeh, Alexandra C Walls, et al.
The New England Journal of Medicine
|
June 5, 2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2017
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Solange Peters, Scott Gettinger, Melissa L Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2021
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Hossein Borghaei, Scott Gettinger, Everett E Vokes, et al.
Nature Communications
|
July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
Gernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
World Neurosurgery
|
February 8, 2021
Surgical or Endovascular Management of Middle Cerebral Artery Aneurysms: A Randomized Comparison
Tim E Darsaut, Michael B Keough, Abdelaziz Sagga, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Nature Communications
|
September 13, 2023
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>De novo</i> design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Page
of 74
Search research articles
Search
Showing results (721-730 of 736) with videos related to
Sort By:
Page
of 74
BMC Medical Education
|
July 2, 2025
Achievement emotions in healthcare education: understanding the application of achievement emotions questionnaire
Fraide A Ganotice, Xiaoai Shen, John Ian Wilzon Tolentino Dizon, et al.
Nature Biotechnology
|
April 28, 2022
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Jason Z Zhang, Hsien-Wei Yeh, Alexandra C Walls, et al.
The New England Journal of Medicine
|
June 5, 2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2017
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Solange Peters, Scott Gettinger, Melissa L Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2021
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Hossein Borghaei, Scott Gettinger, Everett E Vokes, et al.
Nature Communications
|
July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
Gernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
World Neurosurgery
|
February 8, 2021
Surgical or Endovascular Management of Middle Cerebral Artery Aneurysms: A Randomized Comparison
Tim E Darsaut, Michael B Keough, Abdelaziz Sagga, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Nature Communications
|
September 13, 2023
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>De novo</i> design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Anindya Roy, Lei Shi, Ashley Chang, et al.
Page
of 74